Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
Metrics to compare | DMED | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipDMEDPeersSector | |
---|---|---|---|---|
P/E Ratio | −7.0x | −6.1x | −0.5x | |
PEG Ratio | 0.28 | 0.01 | 0.00 | |
Price/Book | −15.0x | 0.3x | 2.6x | |
Price / LTM Sales | - | 2.9x | 3.3x | |
Upside (Analyst Target) | - | 233.7% | 40.3% | |
Fair Value Upside | Unlock | 5.5% | 4.7% | Unlock |